摘要
Abnormal m6A methylation plays a significant role in cancer progression. Increasingly, researchers have focused on developing lncRNA signatures to evaluate the prognosis of cancer patients. The specific function of m6A-related lncRNAs in the prognosis of bladder cancer patients and the immune microenvironment of bladder cancer remains elusive. Herein, we performed a comprehensive analysis of m6A-related lncRNA prognostic values and their association with the immune microenvironment in bladder cancer using the TCGA dataset. A total of 9 m6A-related lncRNAs were dramatically correlated with overall survival outcomes in bladder cancer. Two molecular subtypes (cluster 1 and cluster 2) were identified by consensus clustering for 9 m6A-related prognostic lncRNAs. Cluster 1 was significantly correlated with poor prognosis, advanced clinical stage, higher PD-L1 expression, a higher ESTIMATEScore and immuneScore, and distinct immune cell infiltration. GSEA revealed the enrichment of apoptosis and the JAK-STAT signaling pathway in cluster 2. A prognostic risk score was constructed using 9 m6A-related prognostic lncRNAs, which functioned as an independent prognostic factor for bladder cancer. Moreover, bladder cancer patients in the low-risk score group had a higher pN stage, pT stage, and clinical stage and a lower tumor grade and immuneScore. The risk score was correlated with the infiltration levels of certain immune cells, including B cells, plasma cells, follicular helper T cells, regulatory T cells, resting NK cells, neutrophils, M0 macrophages, M1 macrophages, and M2 macrophages. Collectively, our study elucidated the important role of m6A-related lncRNAs in the prognosis of bladder cancer patients and in the bladder cancer immune microenvironment. The results suggest that the components of the m6A-related prognostic lncRNA signature might serve as a crucial mediator of the immune microenvironment in bladder cancer, representing promising therapeutic targets for improving immunotherapeutic efficacy.
- m6A-immune-related lncRNA prognostic signature for predicting immune landscape and prognosis of bladder cancerFeng, Zi-Hao; Liang, Yan-Ping; Cen, Jun-Jie; Yao, Hao-Hua; Lin, Hai-Shan; Li, Jia-Ying; Liang, Hui; Wang, Zhu; Deng, Qiong; Cao, Jia-Zheng; Huang, Yong; Wei, Jin-Huan; Luo, Jun-Hang*; Chen, Wei*; Chen, Zhen-Hua*Journal of Translational Medicine, 2022, 20(1): 492.被引 15
- Prognosis Risk Model Based on Pyroptosis-Related lncRNAs for Bladder CancerLu, Zechao; Tang, Fucai; Li, Zhichen; Lai, Yongchang; Lu, Zeguang; Zhang, Jiahao; Tang, Zhicheng; Cai, Wanyan; He, Zhaohui*DISEASE MARKERS, 2022, 2022: 7931393.被引 12
- Expression and prognostic signatures of m6A-related lncRNAs in hepatocellular carcinomaHao, Kenan; Li, Jincheng; Zhang, Youao; Zhao, Wei; Chen, Xiaojing; Xu, Jiabin; Tian, Ye; Li, Xinmin; Fen, Jianyu; He, Xiaofeng*Journal of Cancer Research and Clinical Oncology, 2023, 149(8): 4429-4441.被引 2
